Tema Oncology ETF
CANC
5 hedge funds and large institutions have $24.1M invested in Tema Oncology ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
521% more capital invested
Capital invested by funds: $3.87M → $24.1M (+$20.2M)
28.79% more ownership
Funds ownership: 5.11% → 33.9% (+29%)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$20M |
| 2 |
Jane Street
New York
|
+$127K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$7.61K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $23.7M | +$20M | +831,281 | +659% |
|
|
2
Jane Street
New York
| $349K | +$127K | +5,275 | +60% |
|
|
3
Raymond James Financial
St Petersburg,
Florida
| $21.6K | +$21K | +875 | New |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $9.15K | – | – | – |
|
|
PS
5
Principal Securities
Des Moines,
Iowa
| $1.24K | – | – | – |
|
|
HI
6
Harbour Investments
Madison,
Wisconsin
| – | -$7.61K | -316 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$5.37K | -223 | Closed |
|
CANC Hedge Fund Activity: Q2 2025 in Review
5 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q2 2025, worth a combined $24.1M — up 521% from $3.87M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CANC and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $20M. The largest seller was Harbour Investments, exiting entirely with an estimated $7.61K sold.
- 5 institutional investors held Tema Oncology ETF (CANC) as of Q2 2025, down from 6 in Q1 2025.
- Funds reported $24.1M of Tema Oncology ETF stock for Q2 2025, up 521% quarter-over-quarter.
- 1 fund opened new Tema Oncology ETF positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest Tema Oncology ETF buyer in Q2 2025 was Thrivent Financial for Lutherans, an estimated $20M added.
- The largest Tema Oncology ETF seller in Q2 2025 was Harbour Investments, an estimated $7.61K sold.
Based on aggregated 13F filings for Q2 2025.